Roka Bioscience Company Profile (NASDAQ:ROKA)

About Roka Bioscience

Roka Bioscience logoRoka Bioscience, Inc. is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ROKA
  • CUSIP:
Key Metrics:
  • Previous Close: $0.70
  • 50 Day Moving Average: $0.884
  • 200 Day Moving Average: $0.737
  • 52-Week Range: $0.50 - $2.14
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
  • Market Cap: $12.43M
  • Outstanding Shares: 17,884,000
  • Beta: 1.62
Profitability:
  • Net Margins: -530.04%
  • Return on Equity: -82.40%
  • Return on Assets: -49.97%
Debt:
  • Current Ratio: 1.65%
  • Quick Ratio: 1.42%
Additional Links:
Companies Related to Roka Bioscience:

Analyst Ratings

Consensus Ratings for Roka Bioscience (NASDAQ:ROKA) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.50 (115.83% upside)

Analysts' Ratings History for Roka Bioscience (NASDAQ:ROKA)
Show:
DateFirmActionRatingPrice TargetDetails
3/6/2016Leerink SwannDowngradeOutperform -> Market PerformView Rating Details
11/12/2015WedbushLower Price TargetNeutral$3.00 -> $2.00View Rating Details
1/6/2015Bank of America Corp.DowngradeNeutral -> UnderperformView Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Roka Bioscience (NASDAQ:ROKA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016        
8/5/2016Q216($0.43)$1.78 million$1.82 millionViewN/AView Earnings Details
5/4/2016Q116($0.46)($0.47)$1.56 million$1.60 millionViewN/AView Earnings Details
3/4/2016Q415($0.48)($0.56)$1.66 millionViewN/AView Earnings Details
11/11/2015Q315($0.53)($0.49)$1.75 million$1.50 millionViewN/AView Earnings Details
8/13/2015Q215($0.51)($0.54)$1.58 million$1.50 millionViewN/AView Earnings Details
5/7/2015Q115($0.50)($0.51)$1.44 million$1.51 millionViewN/AView Earnings Details
3/26/2015Q414($0.52)($0.43)$1.44 million$1.36 millionViewN/AView Earnings Details
11/10/2014($0.49)($0.64)ViewN/AView Earnings Details
8/11/2014Q214($11.28)$1.40 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Roka Bioscience (NASDAQ:ROKA)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.44)($0.44)($0.44)
Q2 20161($0.42)($0.42)($0.42)
Q3 20161($0.43)($0.43)($0.43)
Q4 20161($0.43)($0.43)($0.43)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Roka Bioscience (NASDAQ:ROKA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Roka Bioscience (NASDAQ:ROKA)
Insider Ownership Percentage: 25.30%
Institutional Ownership Percentage: 65.72%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/17/2014David W J McgirrDirectorBuy50,000$3.60$180,000.00View SEC Filing  
7/22/2014Patrick J KerinsMajor ShareholderBuy383,333$12.00$4,599,996.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Roka Bioscience (NASDAQ:ROKA)
DateHeadline
4-traders.com logoROKA BIOSCIENCE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K) (NASDAQ:ROKA)
www.4-traders.com - September 23 at 11:47 AM
publicnow.com logoRoka Bioscience, Inc. Completes Private Placement of Preferred Stock and Warrants (NASDAQ:ROKA)
www.publicnow.com - September 22 at 11:55 AM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec (NASDAQ:ROKA)
biz.yahoo.com - September 22 at 11:55 AM
News IconInvestor News: Deadline upcoming in Settlement of the Lawsuit against Roka Bioscience Inc (NASDAQ: ROKA) (NASDAQ:ROKA)
www.groundreport.com - September 21 at 11:08 AM
streetinsider.com logoRoka Bioscience (ROKA) Prices $22.5M Series A Preferred Stock Private Placement (NASDAQ:ROKA)
www.streetinsider.com - September 18 at 11:17 AM
4-traders.com logoROKA BIOSCIENCE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) (NASDAQ:ROKA)
www.4-traders.com - September 18 at 11:17 AM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi (NASDAQ:ROKA)
biz.yahoo.com - September 16 at 6:51 PM
finance.yahoo.com logo9:03 am Roka Bioscience enters into $22.5 mln private placement of approx. 22,500 shares of its Series A Preferred Stock (NASDAQ:ROKA)
finance.yahoo.com - September 16 at 10:39 AM
publicnow.com logoRoka Bioscience, Inc. Prices Private Placement of Preferred Stock and Warrants (NASDAQ:ROKA)
www.publicnow.com - September 16 at 10:39 AM
sbwire.com logoFood Safety Testing Market to Grow Steadily at 7.8% CAGR from 2014 - 2021 (NASDAQ:ROKA)
www.sbwire.com - September 7 at 7:13 PM
publicnow.com logoRoka Bioscience to Co-Present Industry Webinar - Play FDA for a day (NASDAQ:ROKA)
www.publicnow.com - September 7 at 7:13 PM
openpr.com logoFood Safety Testing Market will increase 7.8% CAGR by 2021, Says Zion Market Research (NASDAQ:ROKA)
www.openpr.com - September 6 at 7:14 PM
News IconGlobal Food Safety Testing Market expected to reach USD 8.04 Billion by 2021: Zion Market Research (NASDAQ:ROKA)
www.abnewswire.com - September 6 at 7:14 PM
News IconFood Safety Testing Market will hit USD 8.04 Billion worldwide in 2021 (NASDAQ:ROKA)
www.medgadget.com - September 6 at 7:14 PM
openpr.com logoFood Safety Testing Market will reach USD 8.04 Billion in 2021, Globally (NASDAQ:ROKA)
www.openpr.com - September 2 at 12:00 PM
4-traders.com logoCity of Providence RI : Mayor Elorza Statement Regarding LNG Facility (NASDAQ:ROKA)
www.4-traders.com - August 26 at 6:51 PM
openpr.com logoGlobal Food safety testing Market: Industry Size, Share, Trends Analysis and Forecast, 2015 – 2021 (NASDAQ:ROKA)
www.openpr.com - August 19 at 10:06 AM
openpr.com logoFood Safety Testing Market grow at a CAGR of 7.8% between 2016 and 2021 (NASDAQ:ROKA)
www.openpr.com - August 12 at 10:21 AM
openpr.com logoFood Safety Testing Market will Reach USD 8.04 Billion in 2021 (NASDAQ:ROKA)
www.openpr.com - August 10 at 7:40 PM
capitalcube.com logoRoka Bioscience, Inc. :ROKA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:ROKA)
www.capitalcube.com - August 9 at 7:28 PM
publicnow.com logoRoka Bioscience Reports Second Quarter 2016 Financial Results (NASDAQ:ROKA)
www.publicnow.com - August 5 at 10:12 AM
finance.yahoo.com logoMedical Product Stocks' Earnings on Aug 5: XRAY, HMSY & More (NASDAQ:ROKA)
finance.yahoo.com - August 4 at 10:23 AM
publicnow.com logoRoka Bioscience to Report Second Quarter 2016 Financial Results On August 5, 2016 (NASDAQ:ROKA)
www.publicnow.com - July 29 at 8:48 AM
bizjournals.com logoKrensavage Poses Questions to RTI Surgical in Open Letter (NASDAQ:ROKA)
www.bizjournals.com - July 28 at 10:25 AM
finance.yahoo.com logoThe Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Roka Bioscience, Inc. -- ROKA (NASDAQ:ROKA)
finance.yahoo.com - July 25 at 8:00 AM
fxpips.com logoNASDAQ Update: Top Gaining Stocks, July 19 – (NASDAQ:ROKA)
www.fxpips.com - July 19 at 8:09 AM
openpr.com logoSuperbugs and Multiple Drug Resistance to Drive E. coli Diagnostics Testing Market to USD 1.5 Billion by 2020 (NASDAQ:ROKA)
www.openpr.com - July 10 at 11:12 AM
News IconSuperbugs and Multiple Drug Resistance to Drive E. coli Diagnostics Testing Market to USD 1.5 Billion by 2020 - iHealthcareAnalyst, Inc. (NASDAQ:ROKA)
www.pr.com - July 10 at 11:12 AM
4-traders.com logoROKA BIOSCIENCE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) (NASDAQ:ROKA)
www.4-traders.com - June 28 at 7:04 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:ROKA)
biz.yahoo.com - June 27 at 4:16 PM
capitalcube.com logoRoka Bioscience, Inc. :ROKA-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:ROKA)
www.capitalcube.com - May 17 at 3:56 PM
News IconCurrent Price Targets On Roka Bioscience, Inc. (ROKA) - Risers & Fallers (NASDAQ:ROKA)
www.risersandfallers.com - March 15 at 2:58 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 10-K, Annual Report (NASDAQ:ROKA)
biz.yahoo.com - March 9 at 4:13 PM
finance.yahoo.com logoRoka Bioscience downgraded by Leerink Partners (NASDAQ:ROKA)
finance.yahoo.com - March 7 at 6:26 AM
finance.yahoo.com logoRoka Bioscience Reports Fourth Quarter and Full Year 2015 Financial Results (NASDAQ:ROKA)
finance.yahoo.com - March 4 at 4:05 PM
biz.yahoo.com logoQ4 2015 Roka Bioscience Inc Earnings Release - After Market Close (NASDAQ:ROKA)
biz.yahoo.com - March 4 at 7:07 AM
finance.yahoo.com logoRoka Bioscience to Report Fourth Quarter and Full Year 2015 Financial Results on March 4, 2016 (NASDAQ:ROKA)
finance.yahoo.com - February 26 at 4:01 PM
News IconWhat Will Happen to Roka Bioscience Inc Next? The Stock Formed a Several Months Wedge Down - Business Standard Tribune (NASDAQ:ROKA)
www.standardtrib.com - February 26 at 10:25 AM
4-traders.com logoROKA BIOSCIENCE : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) (NASDAQ:ROKA)
www.4-traders.com - February 26 at 10:25 AM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand (NASDAQ:ROKA)
biz.yahoo.com - February 25 at 5:21 PM
clintongazette.com logoHow Many Roka Bioscience Inc (NASDAQ:ROKA)'s Analysts Are Bullish? - Clinton Financial (NASDAQ:ROKA)
www.clintongazette.com - February 20 at 2:55 PM
equities.com logoRoka BioScience Inc. (ROKA) is Trading Lower on Unusual Volume for February 18 - Equities.com (NASDAQ:ROKA)
www.equities.com - February 20 at 2:55 PM
equities.com logoRoka BioScience Inc. (ROKA) is Trading Higher on Unusual Volume for February 19 - Equities.com (NASDAQ:ROKA)
www.equities.com - February 20 at 2:55 PM
News IconAnalyst Coverage Updates – Roka Bioscience, Inc. (ROKA) - Risers & Fallers (NASDAQ:ROKA)
www.risersandfallers.com - February 18 at 2:50 PM
News IconWhat's Propelling Roka Bioscience Inc to Decrease? The Stock Formed a Bearish Wedge Down - Sonoran Weekly Review (NASDAQ:ROKA)
sonoranweeklyreview.com - February 15 at 1:37 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:ROKA)
biz.yahoo.com - February 10 at 4:14 PM
News IconMomentum Stock: Roka Bioscience Inc - CWRU Observer (NASDAQ:ROKA)
cwruobserver.com - February 10 at 2:05 PM
News IconLatest Analysts Reports On Roka Bioscience, Inc. (ROKA) - Risers & Fallers (NASDAQ:ROKA)
www.risersandfallers.com - February 8 at 1:32 PM
prnewswire.com logoNicholas Valeriani Appointed to Roka Bioscience's Board of Directors (NASDAQ:ROKA)
www.prnewswire.com - February 6 at 2:09 PM
investornewswire.com logoRoka Bioscience, Inc. (NASDAQ:ROKA): Quarterly Earnings Update - Investor Newswire (NASDAQ:ROKA)
www.investornewswire.com - February 3 at 12:42 PM

Social

Roka Bioscience (NASDAQ:ROKA) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff